Bim contributes to the progression of Huntington's disease-associated phenotypes

Hum Mol Genet. 2020 Jan 15;29(2):216-227. doi: 10.1093/hmg/ddz275.

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded polyglutamine tract in the huntingtin (HTT) protein. Mutant HTT (mHTT) toxicity is caused by its aggregation/oligomerization. The striatum is the most vulnerable region, although all brain regions undergo neuronal degeneration in the disease. Here we show that the levels of Bim, a BH3-only protein, are significantly increased in HD human post-mortem and HD mouse striata, correlating with neuronal death. Bim reduction ameliorates mHTT neurotoxicity in HD cells. In the HD mouse model, heterozygous Bim knockout significantly mitigates mHTT accumulation and neuronal death, ameliorating disease-associated phenotypes and lifespan. Therefore, Bim could contribute to the progression of HD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Animals
  • Bcl-2-Like Protein 11 / genetics
  • Bcl-2-Like Protein 11 / metabolism*
  • Corpus Striatum / metabolism*
  • Corpus Striatum / pathology
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Gene Knockout Techniques
  • Heterozygote
  • Humans
  • Huntingtin Protein / genetics*
  • Huntingtin Protein / metabolism
  • Huntington Disease / genetics
  • Huntington Disease / metabolism*
  • Huntington Disease / mortality
  • Huntington Disease / pathology
  • Male
  • Mice
  • Middle Aged
  • Neurons / metabolism
  • Neurons / pathology*
  • Phenotype
  • Protein Aggregates / genetics
  • RNA, Small Interfering

Substances

  • Bcl-2-Like Protein 11
  • Bcl2l11 protein, mouse
  • Huntingtin Protein
  • Protein Aggregates
  • RNA, Small Interfering